News

India’s TB Battle Explored: BBC News’ Insights on VPM1002

5th January 2024

Collaborating with Serum Institute of India Pvt. Ltd., we are proud partners in advancing the groundbreaking TB vaccine candidate, VPM1002. For deeper insights into our efforts, explore BBC’s coverage on…

Wrapping Up priMe’s Annual Meeting: A Journey Towards Success

30th November 2023

With a round of applause and a plethora of insights, Day 2 marks the exciting conclusion of our priMe trial meeting in Entebbe, Uganda. Highlights of Day Two: Collective…

First Day Insights from the priMe Annual Meeting

29th November 2023

TUSANYUSE NYO OBALABA (Welcome everyone in Luganda language) The first day at the annual meeting of the pivotal priMe trial held in Entebbe, Uganda, was marked by significant discussions and…

The priMe Trial Gathers Momentum

20th November 2023

We are thrilled to announce the annual meeting for the pivotal phase III trial , priMe, set to take place in Entebbe, Uganda on November 29-30, 2023. This collaborative effort…

Recap: SLS Europe at BioEurope and EDCTP Forum

14th November 2023

Last week, SLS Europe was an active participant in two influential events: BioEurope 2023 in Munich and the Eleventh EDCTP Forum in Paris. Our goal was to gain the latest…

Clinical trial results for SIIPL Tdap are online

1st November 2023

The Phase II/III study, conducted in Germany, assessed the safety and immunogenicity of SIIPL Tdap, a novel booster vaccine for tetanus, diphtheria, and pertussis. This publication represents a significant step…

SLS Europe is attending the 11th EDCTP Forum

1st November 2023

With the theme ‘Partnering for Global Health Research Innovation in Africa – Celebrating Two Decades of EDCTP,’ we’re excited to be part of this milestone event. The event will take…

WHO recommends R21/Matrix-M vaccine for malaria prevention

10th October 2023

Serum Life Science Europe GmbH (SLS Europe) is delighted to announce the recommendation by the World Health Organization (WHO) for the novel R21/Matrix-M Malaria Vaccine for prevention of malaria in…

Stefan Kaufmann Advocates for Advancements in Tuberculosis Control

2nd August 2023

Renowned vaccine researcher, Prof. Dr. Stefan H. E. Kaufmann, recently shared his expertise and insights on tuberculosis in an exclusive interview with ETHealthworld. Prof. Dr. Kaufmann, the inventor of VPM1002,…

VPM helps facilitate fast track designation for Memo Therapeutics AG’s AntiBKV first-in-class treatment for BK virus infection in renal transplant recipients

11th May 2023

VPM helps facilitate fast track designation for Memo Therapeutics AG’s AntiBKV first-in-class treatment for BK virus infection in renal transplant recipients Vakzine Projekt Management GmbH (VPM) announced today that it…